<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Although <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e> and Epstein-Barr (EBV) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> are recognized cofactors in the genesis of endemic Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>), their relative contribution is not understood </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>, the most common paediatric <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in equatorial Africa, is a high-grade B cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> characterized by c-myc translocation </plain></SENT>
<SENT sid="2" pm="."><plain>EBV is a ubiquitous B lymphotropic virus that persists in a latent state after <z:e sem="disease" ids="C0948192" disease_type="Disease or Syndrome" abbrv="">primary infection</z:e>, and in Africa, most children have sero-converted by 3 y of age </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">Malaria</z:e> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> profoundly affects the B cell compartment, inducing polyclonal activation and hyper-<z:e sem="disease" ids="C1168356" disease_type="Disease or Syndrome" abbrv="">gammaglobulinemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>We recently identified the <z:chebi fb="0" ids="15356">cystein</z:chebi>-rich inter-domain region 1alpha (CIDR1alpha) of the Plasmodium falciparum membrane protein 1 as a polyclonal B cell activator that preferentially activates the memory compartment, where EBV is known to persist </plain></SENT>
<SENT sid="5" pm="."><plain>Here, we have addressed the mechanisms of interaction between CIDR1alpha and EBV in the context of B cells </plain></SENT>
<SENT sid="6" pm="."><plain>We show that CIDR1alpha binds to the EBV-positive B cell line Akata and increases the number of cells switching to the <z:mp ids='MP_0001799'>viral</z:mp> lytic cycle as measured by green fluorescent protein (GFP) expression driven by a lytic promoter </plain></SENT>
<SENT sid="7" pm="."><plain>The virus production in CIDR1alpha-exposed cultures was directly proportional to the number of GFP-positive Akata cells (lytic EBV) and to the increased expression of the EBV lytic promoter BZLF1 </plain></SENT>
<SENT sid="8" pm="."><plain>Furthermore, CIDR1alpha stimulated the production of EBV in peripheral blood mononuclear cells derived from healthy donors and children with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Our results suggest that P. falciparum antigens such as CIDR1alpha can directly induce EBV reactivation during <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> that may increase the risk of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> development for children living in <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e>-endemic areas </plain></SENT>
<SENT sid="10" pm="."><plain>To our knowledge, this is the first report to show that a microbial protein can drive a latently infected B cell into EBV replication </plain></SENT>
</text></document>